APA (7th ed.) Citation

Ferro, J. M., & Nagel, S. (2019). Safety and efficacy of Dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: A randomized clinical trial. JAMA neurology, 76(12), . https://doi.org/10.1001/jamaneurol.2019.2764

Chicago Style (17th ed.) Citation

Ferro, José M., and Simon Nagel. "Safety and Efficacy of Dabigatran Etexilate Vs Dose-adjusted Warfarin in Patients with Cerebral Venous Thrombosis: A Randomized Clinical Trial." JAMA Neurology 76, no. 12 (2019). https://doi.org/10.1001/jamaneurol.2019.2764.

MLA (9th ed.) Citation

Ferro, José M., and Simon Nagel. "Safety and Efficacy of Dabigatran Etexilate Vs Dose-adjusted Warfarin in Patients with Cerebral Venous Thrombosis: A Randomized Clinical Trial." JAMA Neurology, vol. 76, no. 12, 2019, https://doi.org/10.1001/jamaneurol.2019.2764.